Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity
Clinical trial NCT03821402 · COMPLETED
Trial details
- NCT number
- NCT03821402
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2020-11-23
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.